News & Updates
Filter by Specialty:

Dual antiplatelet therapy after minor, warning stroke: A missed opportunity
Not a lot of individuals, especially women, are initiated on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel after a transient ischaemic attack or minor acute ischaemic stroke, and this is despite evidence showing that such a strategy may prevent a second and potentially more serious stroke, as reported in a study presented at ISC 2023.
Dual antiplatelet therapy after minor, warning stroke: A missed opportunity
24 Feb 2023
Hong Kong’s first support programme for younger-onset dementia
Hong Kong’s first younger-onset dementia (YOD) support programme is launched recently to provide free diagnostic, referral and follow-up services to individuals aged 40–65 years with suspected or diagnosed YOD.
Hong Kong’s first support programme for younger-onset dementia
24 Feb 2023
Celery seed-derived drug beneficial in ischaemic stroke patients
Butylphthalide, a novel medication that contains a compound found in celery, appears to help with functional recovery in patients with ischaemic stroke, as shown in a study presented at ISC 2023.
Celery seed-derived drug beneficial in ischaemic stroke patients
22 Feb 2023
DAPT with cilostazol reduces stroke recurrence without raising bleeding risk
Dual antiplatelet therapy (DAPT) using cilostazol appears to be more beneficial than single antiplatelet therapy, with the results of a study suggesting that DAPT helps lower the incidence of ischemic stroke recurrence without increasing the risk of severe or life-threatening bleeding.